Target intelligence / Profile preview

3,5,6-trichloro-2-pyridinol monooxygenase (TcpA)

Target
TcpA
Molecular classification
Enzyme, Oxidoreductase, Monooxygenase, Flavin-dependent monooxygenase
01

Overview

3,5,6-Trichloro-2-pyridinol (TCP) monooxygenase is a microbial enzyme responsible for the initial step in the biodegradation of TCP, a persistent and toxic metabolite of the organophosphate insecticide chlorpyrifos and the herbicide triclopyr. TCP is an environmental pollutant characterized by its mobility in soil and aquatic environments and is a known endocrine disruptor in humans and animals, associated with conditions such as decreased testosterone levels and attention deficit hyperactivity disorder (ADHD). The enzyme TcpA, often a flavin-dependent monooxygenase, catalyzes the oxidative dechlorination of TCP into less toxic intermediates like 3,6-dihydroxypyridine-2,5-dione (DHPD), facilitating its complete mineralization. While it is not a therapeutic drug target for human diseases, it is a significant target for environmental biotechnology and bioremediation efforts aimed at detoxifying pesticide-contaminated sites. Understanding the molecular mechanism of this enzyme is crucial for developing bacterial strains capable of rapid and efficient environmental cleanup of chlorinated xenobiotics.

Other names
3,5,6-trichloro-2-pyridinol monooxygenaseTCP monooxygenase3,5,6-trichloro-2-pyridinol degrading enzymeTcpATcp3A3,5,6-trichloro-2-pyridinol dioxygenase
02

Mechanism of action

Oxidative dechlorination of 3,5,6-trichloro-2-pyridinol to 3,6-dihydroxypyridine-2,5-dione (DHPD)

03

Biological functions

BiodegradationXenobiotic metabolismDechlorinationEnvironmental remediation
04

Disease associations

Pesticide toxicityEndocrine disruptionOther
05

Safety considerations

Persistence of chlorinated metabolites in the environmentAccumulation of toxic degradation intermediatesIncomplete mineralization in non-optimized conditions
06

Biomarkers

Urinary 3,5,6-trichloro-2-pyridinol (TCPy)

Beyond the preview

Go deeper on 3,5,6-trichloro-2-pyridinol monooxygenase (TcpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3,5,6-trichloro-2-pyridinol monooxygenase (TcpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call